Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Bausch & Lomb
>
B&L is doing well under new owners
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 5244789"]Valeant boasted to shareholders that they cut over $900M with the B+L acquisition , much of that in R&D. Now we're to believe they're spending more than ever in R&D. </p><p><br /></p><p>Sorry Valeant, can't have it both ways.[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 5244789"]Valeant boasted to shareholders that they cut over $900M with the B+L acquisition , much of that in R&D. Now we're to believe they're spending more than ever in R&D. Sorry Valeant, can't have it both ways.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Bausch & Lomb
>
B&L is doing well under new owners
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Bausch & Lomb
>
B&L is doing well under new owners
>